Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VINGEM: Vinflunine/Gemcitabine vs Carboplatin/Gemcitabine in Urothelial Carcinoma
NCT02665039Phase 2Completed
- Start
- Apr 2014
- Primary completion
- Sep 2018
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vinflunine in urothelial carcinoma (UC). Started Apr 2014; status: completed.
02
Drugs
vinflunine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT02665039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665039.